Dechert advised Biomunex Pharmaceuticals on the deal. Biomunex Pharmaceuticals, a French biopharmaceutical company, closed a strategic exclusive worldwide license and co-development agreement with Onward Therapeutics SA...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here